(2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide

C160H157F7N50O24S — CID 161469437

IUPAC(2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide
SMILESCCC(=O)Cn1c(=O)c2c(ncn2[C@@H](C)C(=O)Nc2cncc(-c3ccc(N4CC5C(C4)C5(F)F)nc3)n2)n(C)c1=O.COCC(=O)Cn1c(=O)c2c(ncn2[C@@H](C)C(=O)Nc2cccc(-c3cnc(N4CC5CC5C4)cn3)n2)n(C)c1=O.COCC(=O)Cn1c(=O)c2c(ncn2[C@@H](C)C(=O)Nc2csc(-c3cnc(N4CC5C(C4)C5(C)F)nc3)n2)n(C)c1=O.Cc1cc(Cn2c(=O)c3c(ncn3[C@@H](C)C(=O)Nc3ccnc(-c4cnc(C(F)(F)F)c(C)c4)n3)n(C)c2=O)no1.Cc1ccc(-c2cccc(NC(=O)Cn3c(C)nc4c3c(=O)n(Cc3ccccn3)c(=O)n4C)n2)cc1.Cc1ccc(-c2cccc(NC(=O)[C@H](C)n3c(C)nc4c3c(=O)n(Cc3ccccn3)c(=O)n4C)n2)cc1F
InChIInChI=1S/C28H26FN7O3.C27H27F2N9O4.C27H29N9O5.C27H25N7O3.C26H28FN9O5S.C25H22F3N9O4/c1-16-11-12-19(14-21(16)29)22-9-7-10-23(32-22)33-26(37)17(2)36-18(3)31-25-24(36)27(38)35(28(39)34(25)4)15-20-8-5-6-13-30-20;1-4-16(39)10-37-25(41)22-23(35(3)26(37)42)32-13-38(22)14(2)24(40)34-20-9-30-8-19(33-20)15-5-6-21(31-7-15)36-11-17-18(12-36)27(17,28)29;1-15(36-14-30-24-23(36)26(39)35(27(40)33(24)2)12-18(37)13-41-3)25(38)32-21-6-4-5-19(31-21)20-8-29-22(9-28-20)34-10-16-7-17(16)11-34;1-17-10-12-19(13-11-17)21-8-6-9-22(30-21)31-23(35)16-33-18(2)29-25-24(33)26(36)34(27(37)32(25)3)15-20-7-4-5-14-28-20;1-13(36-12-30-20-19(36)23(39)35(25(40)33(20)3)7-15(37)10-41-4)21(38)31-18-11-42-22(32-18)14-5-28-24(29-6-14)34-8-16-17(9-34)26(16,2)27;1-12-7-15(9-30-19(12)25(26,27)28)20-29-6-5-17(32-20)33-22(38)14(3)37-11-31-21-18(37)23(39)36(24(40)35(21)4)10-16-8-13(2)41-34-16/h5-14,17H,15H2,1-4H3,(H,32,33,37);5-9,13-14,17-18H,4,10-12H2,1-3H3,(H,33,34,40);4-6,8-9,14-17H,7,10-13H2,1-3H3,(H,31,32,38);4-14H,15-16H2,1-3H3,(H,30,31,35);5-6,11-13,16-17H,7-10H2,1-4H3,(H,31,38);5-9,11,14H,10H2,1-4H3,(H,29,32,33,38)/t17-;14-,17?,18?;15-,16?,17?;;13-,16?,17?,26?;14-/m000.00/s1
InChIKeyWCWKAFRAWZCWKV-LVUZFRTGSA-N
MW3329.39 g/mol
LogP11.90
Rot. Bonds44

About (2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide

(2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide (PubChem CID 161469437) has the molecular formula C160H157F7N50O24S and a molecular weight of 3329.39 g/mol. Its IUPAC name is (2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide.

Molecular Properties

Compound Name(2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide
PubChem CID161469437
Molecular FormulaC160H157F7N50O24S
Molecular Weight3329.39 g/mol
Exact Mass3327.22
IUPAC Name(2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide
SMILESCCC(=O)Cn1c(=O)c2c(ncn2[C@@H](C)C(=O)Nc2cncc(-c3ccc(N4CC5C(C4)C5(F)F)nc3)n2)n(C)c1=O.COCC(=O)Cn1c(=O)c2c(ncn2[C@@H](C)C(=O)Nc2cccc(-c3cnc(N4CC5CC5C4)cn3)n2)n(C)c1=O.COCC(=O)Cn1c(=O)c2c(ncn2[C@@H](C)C(=O)Nc2csc(-c3cnc(N4CC5C(C4)C5(C)F)nc3)n2)n(C)c1=O.Cc1cc(Cn2c(=O)c3c(ncn3[C@@H](C)C(=O)Nc3ccnc(-c4cnc(C(F)(F)F)c(C)c4)n3)n(C)c2=O)no1.Cc1ccc(-c2cccc(NC(=O)Cn3c(C)nc4c3c(=O)n(Cc3ccccn3)c(=O)n4C)n2)cc1.Cc1ccc(-c2cccc(NC(=O)[C@H](C)n3c(C)nc4c3c(=O)n(Cc3ccccn3)c(=O)n4C)n2)cc1F
InChIInChI=1S/C28H26FN7O3.C27H27F2N9O4.C27H29N9O5.C27H25N7O3.C26H28FN9O5S.C25H22F3N9O4/c1-16-11-12-19(14-21(16)29)22-9-7-10-23(32-22)33-26(37)17(2)36-18(3)31-25-24(36)27(38)35(28(39)34(25)4)15-20-8-5-6-13-30-20;1-4-16(39)10-37-25(41)22-23(35(3)26(37)42)32-13-38(22)14(2)24(40)34-20-9-30-8-19(33-20)15-5-6-21(31-7-15)36-11-17-18(12-36)27(17,28)29;1-15(36-14-30-24-23(36)26(39)35(27(40)33(24)2)12-18(37)13-41-3)25(38)32-21-6-4-5-19(31-21)20-8-29-22(9-28-20)34-10-16-7-17(16)11-34;1-17-10-12-19(13-11-17)21-8-6-9-22(30-21)31-23(35)16-33-18(2)29-25-24(33)26(36)34(27(37)32(25)3)15-20-7-4-5-14-28-20;1-13(36-12-30-20-19(36)23(39)35(25(40)33(20)3)7-15(37)10-41-4)21(38)31-18-11-42-22(32-18)14-5-28-24(29-6-14)34-8-16-17(9-34)26(16,2)27;1-12-7-15(9-30-19(12)25(26,27)28)20-29-6-5-17(32-20)33-22(38)14(3)37-11-31-21-18(37)23(39)36(24(40)35(21)4)10-16-8-13(2)41-34-16/h5-14,17H,15H2,1-4H3,(H,32,33,37);5-9,13-14,17-18H,4,10-12H2,1-3H3,(H,33,34,40);4-6,8-9,14-17H,7,10-13H2,1-3H3,(H,31,32,38);4-14H,15-16H2,1-3H3,(H,30,31,35);5-6,11-13,16-17H,7-10H2,1-4H3,(H,31,38);5-9,11,14H,10H2,1-4H3,(H,29,32,33,38)/t17-;14-,17?,18?;15-,16?,17?;;13-,16?,17?,26?;14-/m000.00/s1
InChIKeyWCWKAFRAWZCWKV-LVUZFRTGSA-N
XLogP11.90
TPSA857.18 Ų
H-Bond Donors6
H-Bond Acceptors69
Rotatable Bonds44
Heavy Atoms242
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003329.39
LogP ≤ 511.90
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1069

Analyze (2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide?
The IUPAC name of (2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide (CID 161469437) is (2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide.
What is the SMILES notation for (2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide?
The canonical SMILES for (2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide is CCC(=O)Cn1c(=O)c2c(ncn2[C@@H](C)C(=O)Nc2cncc(-c3ccc(N4CC5C(C4)C5(F)F)nc3)n2)n(C)c1=O.COCC(=O)Cn1c(=O)c2c(ncn2[C@@H](C)C(=O)Nc2cccc(-c3cnc(N4CC5CC5C4)cn3)n2)n(C)c1=O.COCC(=O)Cn1c(=O)c2c(ncn2[C@@H](C)C(=O)Nc2csc(-c3cnc(N4CC5C(C4)C5(C)F)nc3)n2)n(C)c1=O.Cc1cc(Cn2c(=O)c3c(ncn3[C@@H](C)C(=O)Nc3ccnc(-c4cnc(C(F)(F)F)c(C)c4)n3)n(C)c2=O)no1.Cc1ccc(-c2cccc(NC(=O)Cn3c(C)nc4c3c(=O)n(Cc3ccccn3)c(=O)n4C)n2)cc1.Cc1ccc(-c2cccc(NC(=O)[C@H](C)n3c(C)nc4c3c(=O)n(Cc3ccccn3)c(=O)n4C)n2)cc1F.
What is the InChIKey of (2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide?
The InChIKey is WCWKAFRAWZCWKV-LVUZFRTGSA-N. The full InChI is InChI=1S/C28H26FN7O3.C27H27F2N9O4.C27H29N9O5.C27H25N7O3.C26H28FN9O5S.C25H22F3N9O4/c1-16-11-12-19(14-21(16)29)22-9-7-10-23(32-22)33-26(37)17(2)36-18(3)31-25-24(36)27(38)35(28(39)34(25)4)15-20-8-5-6-13-30-20;1-4-16(39)10-37-25(41)22-23(35(3)26(37)42)32-13-38(22)14(2)24(40)34-20-9-30-8-19(33-20)15-5-6-21(31-7-15)36-11-17-18(12-36)27(17,28)29;1-15(36-14-30-24-23(36)26(39)35(27(40)33(24)2)12-18(37)13-41-3)25(38)32-21-6-4-5-19(31-21)20-8-29-22(9-28-20)34-10-16-7-17(16)11-34;1-17-10-12-19(13-11-17)21-8-6-9-22(30-21)31-23(35)16-33-18(2)29-25-24(33)26(36)34(27(37)32(25)3)15-20-7-4-5-14-28-20;1-13(36-12-30-20-19(36)23(39)35(25(40)33(20)3)7-15(37)10-41-4)21(38)31-18-11-42-22(32-18)14-5-28-24(29-6-14)34-8-16-17(9-34)26(16,2)27;1-12-7-15(9-30-19(12)25(26,27)28)20-29-6-5-17(32-20)33-22(38)14(3)37-11-31-21-18(37)23(39)36(24(40)35(21)4)10-16-8-13(2)41-34-16/h5-14,17H,15H2,1-4H3,(H,32,33,37);5-9,13-14,17-18H,4,10-12H2,1-3H3,(H,33,34,40);4-6,8-9,14-17H,7,10-13H2,1-3H3,(H,31,32,38);4-14H,15-16H2,1-3H3,(H,30,31,35);5-6,11-13,16-17H,7-10H2,1-4H3,(H,31,38);5-9,11,14H,10H2,1-4H3,(H,29,32,33,38)/t17-;14-,17?,18?;15-,16?,17?;;13-,16?,17?,26?;14-/m000.00/s1.
What are the key properties of (2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide?
(2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide has a molecular weight of 3329.39 g/mol, XLogP of 11.90, 44 rotatable bonds, 6 hydrogen bond donors, and 69 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[6-[5-(3-azabicyclo[3.1.0]hexan-3-yl)pyrazin-2-yl]-2-pyridinyl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-N-[6-[6-(6,6-difluoro-3-azabicyclo[3.1.0]hexan-3-yl)-3-pyridinyl]pyrazin-2-yl]-2-[3-methyl-2,6-dioxo-1-(2-oxobutyl)purin-7-yl]propanamide;(2S)-2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(3-fluoro-4-methylphenyl)-2-pyridinyl]propanamide;2-[3,8-dimethyl-2,6-dioxo-1-(pyridin-2-ylmethyl)purin-7-yl]-N-[6-(4-methylphenyl)-2-pyridinyl]acetamide;(2S)-N-[2-[2-(6-fluoro-6-methyl-3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-5-yl]-1,3-thiazol-4-yl]-2-[1-(3-methoxy-2-oxopropyl)-3-methyl-2,6-dioxopurin-7-yl]propanamide;(2S)-2-[3-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-2,6-dioxopurin-7-yl]-N-[2-[5-methyl-6-(trifluoromethyl)-3-pyridinyl]pyrimidin-4-yl]propanamide is sourced from PubChem (CID 161469437), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).